Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease
Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease
Active, not recruiting · NCT06851806 · Registry updated 2026-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease | Respiratory Syncytial Virus (RSV) | Active, not recruiting | Not applicable | 2026-09-09 | NCT06851806 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||